Public Market Listing
128940KOSPI
Live quotes, historical charts, and market capitalization for Hanmi Pharmaceutical are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(5 total)
5Total Assets
0Approved
1Phase 3 / Filed
4Phase 1–2 / Early
4Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | GLP-1 receptorPeptide | Type 2 Diabetes | |
| Phase 2 | GLP-1/GIP/glucagon receptor (triple)Peptide | Obesity | |
| Phase 2 | GLP-1/GIP/glucagon receptor (triple)Peptide | Obesity | |
| Phase 1/2 | FLT3 (wild-type and mutant, including ITD/TKD), SYKSmall molecule | Acute Myeloid Leukemia | |
CavirNo recent activity | Preclinical / Unstaged | —Small molecule | Chronic Hepatitis B |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.